SLC6A2 and laryngotracheoesophageal cleft: Although neurotransmitter dysregulation was not significantly enriched through initial pathway analysis, the abnormal expression of SLC6A2 and SNAP25 in LC patients suggests dysfunctional neurotransmitter expression.